# Iguratimod in Systemic Sclerosis

> **NCT04515706** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Systemic Sclerosis, Diffuse

## Interventions

- **DRUG:** Iguratimod
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04515706
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-01
- **Primary completion:** 2023-01-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04515706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04515706, "Iguratimod in Systemic Sclerosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04515706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*